✦ LIBER ✦

Passive anti-amyloid immunotherapy in Alzheimer's disease: What are the most promising targets?

✍ Scribed by Jens Moreth, Chrystelle Mavoungou, Katharina Schindowski

Book ID: 120693115
Publisher: BioMed Central
Year: 2013
Tongue: English
Weight: 365 KB
Volume: 10
Category: Article
ISSN: 1742-4933
DOI: 10.1186/1742-4933-10-18

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Targeting histone-modifications in Alzhe

Targeting histone-modifications in Alzheimer's disease. What is the evidence that this is a promising therapeutic avenue?

✍ Fischer, Andre 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 427 KB

Inhibition of Acetylcholinesterase, β-Am

Inhibition of Acetylcholinesterase, β-Amyloid Aggregation, and NMDA Receptors in Alzheimer’s Disease: A Promising Direction for the Multi-target-Directed Ligands Gold Rush

✍ Simoni, Elena; Bartolini, Manuela; Cavalli, Andrea; Ceccarini, Luisa; Pascu, Nic 📂 Article 📅 2008 🏛 American Chemical Society 🌐 English ⚖ 152 KB

O1-03-02: In vivo targeting of antibody

O1-03-02: In vivo targeting of antibody fragments to the nervous system for Alzheimer’s disease immunotherapy and molecular imaging of amyloid plaques

✍ Joseph F. Poduslo; Silvina S. Holasek; Muthu Ramakrishnan; Marina Ramirez-Alvara 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Cysteine proteases are the major β-secre

Cysteine proteases are the major β-secretase in the regulated secretory pathway that provides most of the β-amyloid in Alzheimer's disease: Role of BACE 1 in the constitutive secretory pathway

✍ Vivian Y.H. Hook; Terry D. Reisine 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 410 KB

## Abstract This article focuses on β‐amyloid (Aβ) peptide production and secretion in the regulated secretory pathway and how this process relates to accumulation of toxic Aβ in Alzheimer's disease. New findings are presented demonstrating that most of the Aβ is produced and secreted, in an activi